Gilead Sciences

Gilead Sciences (Foster City, CA). 2024 revenue ~$28B. Antivirals: Biktarvy (HIV), Veklury (remdesivir), Sovaldi (HCV). Oncology: Kite Pharma (CAR-T, Yescarta). Nucleotide analog synthesis expertise.